KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Moderna (MRNA) Current Taxes: 2021-2023

Historic Current Taxes for Moderna (MRNA) over the last 3 years, with Dec 2023 value amounting to $63.0 million.

  • Moderna's Current Taxes fell 92.86% to $4.0 million in Q3 2024 from the same period last year, while for Sep 2024 it was $4.0 million, marking a year-over-year decrease of 92.86%. This contributed to the annual value of $63.0 million for FY2023, which is 31.25% up from last year.
  • Latest data reveals that Moderna reported Current Taxes of $63.0 million as of FY2023, which was up 31.25% from $48.0 million recorded in FY2022.
  • Over the past 5 years, Moderna's Current Taxes peaked at $876.0 million during FY2021, and registered a low of $48.0 million during FY2022.
  • Its 3-year average for Current Taxes is $329.0 million, with a median of $63.0 million in 2023.
  • In the last 5 years, Moderna's Current Taxes tumbled by 94.52% in 2022 and then surged by 31.25% in 2023.
  • Over the past 3 years, Moderna's Current Taxes (Yearly) stood at $876.0 million in 2021, then tumbled by 94.52% to $48.0 million in 2022, then spiked by 31.25% to $63.0 million in 2023.